Abstract: Glycogen synthase kinase 3β (GSK3β) was discovered as a major factor in glucose homeostasis. GSK3 β is a pivotal regulator of glycogen synthesis by altering the activity of glycogen synthase and perturbation in this process have been linked to at least some sub-entities of insulin resistance and diabetes mellitus. However, GSK3β has a central role in many biochemical and physiological processes apparently not related to insulin resistance or diabetes. The functionality of GSK3 β is vast including more than 33 substrates and 72 protein-protein interactions, and is involved in such diverse diseases as cancer, schizophrenia, inflamation, cardiac diseases and many more. Considering this scale of the involvement of GSK3β, many related to developmental processes, suggests that either is GSK3β a high-level network-hub or is a peripheral kinase in several non-connected networks. Here, evidence is provided that GSK3 β is an ultraconserved protein which would suggest that the enzyme qualify to be a kernel protein in the sense that life as we know it depends on conserved molecular entities to provide the essential functionality to an organism. The enzyme has evolved under strong purifying selection implicating that GSK3β is a functional hub.
Introduction
The Cambrian explosion, which happened approximately 540 million years ago (Mya), refers to the vast expansion of living species. Although extensive diversions of species between and within the phyla since then are encountered, only minor changes have occurred in the grand body plans of even apparently remote species. It has been suggested that concomitant preservation of the basic body plan and the divergent evolution of phyla and species is reflected in the hierarchical structure of modular structures of multigenic regulatory networks. 1 On top of this hierarchy are the ultraconserved regulatory subcircuits which comprise the upstream blue print of the body plan and are as such considered the kernel of the organism. Beneath this level are several evolving regulatory subcircuits and modullary structures determining the development and diversion of intra-phyla species. In the bottom of the hierarchy are the effectors of biological processes i.e. proteins involved in metabolic processes, signal transduction, and as structural cellular components. The concept of kernel structures thus refers to a collection of genes encoding transcription factors dedicated to execute the blue print of the basic body plan. The individual transcription factors may participate in subsequent regulatory processes, but the essential point is that the kernels are functionally integrated structures of genes and any perturbation of a kernel is detrimental to the developmental purpose of the kernel resulting in the lack of development of a particular body part or even being lethal to the organism, and hence the kernel structure and participating genes are extremely conserved.
Genes evolves as a consequence of selection pressures, which is intimately (but not exclusively) related to the functionality of the genes products i.e. the proteins. Proteins are involved in all aspects of cellular processes: organisation of the genome, transcription, translation, organelle constructions, mechanic structures and cellular skeletons, transport of metabolites, as enzymes, and signal transduction and regulation. They are engaged in complex interactions in networks with other proteins and metabolites, and are central to all physiological processes and phenotypic expression of unicellular as well as multicellular organisms. Proteins may not be restricted to a single functionality, but may differ in their function in context-specific ways.
A prime example of this multifunctionality is glycogen synthase kinase 3 beta (GSK3β) which phosphorylates at least 33 substrates and interacts with at least 72 proteins participating in numerous metabolic processes, signal transductions, and cellular structures (collated in Human Protein Reference Database, http:// www.hprd.org). GSK3β was baptised so because it was initially described as the key enzyme in glycogen metabolism-which it is indeed. 2 As such the functionality and regulation GSK3β is a major contributor to the homeostasis of glucose, but as indicated above the functionality of this kinase goes far beyond the regulation of glucose homeostasis. Considering the numerous and diverse processes that involves GSK3β two extreme scenarios can be imagined: 1) GSK3β is evolutionary diverse and rather non-conserved allowing for extensive intra-species variation, and is not a hub in any of the networks governing the physiological processes it is part of; or 2) GSK3β is a component (even as a hub) in networks of proteins and is pivotal to essential processes in diverse and phylogenetically distant species, and perturbations of GSK3β may have detrimental effects on cells and organisms, hence GSK3β is highly conserved through evolution. After a short review of regulatory aspects of GSK3β, we argue and provide evidence for the latter scenario.
Glycogen synthase Kinase 3β
GSK3β is located on chromosome 3q13.3-q21 and is expressed in almost all tissues including muscle, brain, kidney, testes, thymus, prostate and ovary in humans. 3 GSK3β is usually constitutively activated by phosphorylation of Tyr216, [4] [5] [6] which may be the result of an autophosphorylation process. 7 The ubiquitous mechanism of inhibition of GSK3β is by phosphorylation of serine 9 (Ser9), but other mechanisms are operative. GSK3β is involved in a plethora of biochemical processes, which raises the question how specificity is obtained. This is obtained by several signalling pathways, compartmentalizing of GSK3β and its substrates, and by mechanisms not related to the phosphorylation status of GSK3β. The major pathways and mechansms are summarized below. Much direct evidence have been present, some conclusions are by inference, and most of all, we still have much to learn.
Akt (protein kinase B, PKB) phosphorylation, as in
the insulin signalling cascade, includes the insulin receptor substrate 1 (IRS1), phosphatidylinositol-3-kinase (PI3K), and 3-phosphoinositide-dependent kinase (PDK1), resulting in activation of Akt and subsequently phosphorylation of Ser9 in the cytoplasmatic pool of GSK3β. A characteristic of this pathway is that the substrates have to be primed by phophorylation by other kinases. In addition, insulin stimulates protein phosphatases which dephosphorylates and thereby activates substrates of GSK3β such as glycogen synthase and the eukaryotic initiation factor 2B, eIF2B 8 promoting glycogen and protein synthesis. Thus, GSK3β is an anti-anabolic kinase. Recently it has been proposed that spingosine-1-phosphate (S1P) induces a time-dependent activation of the PI3K/PDK1/Akt pathway stimulating a migratory response in vascular smooth muscle cells. The activation of the pathway induces the anticipated decrease in GSK3β. 9 This action of S1P links GSK3β to the intricate balance of the ceramide/S1P signalling system with the apoptotic effects of ceramide opposing the S1P stimulation of cell proliferation. 10 It is not known if there is a feed-back regulation of the ceramide/S1P pathway by GSK3β. 2. The Wnt-pathway. The lipoproteins Wnt ligands (Wingless in Drosophila melanogaster) suppress the activity of GSK3β, through the activation of the Frizzled receptors 8 and the co-receptors lipoprotein receptor-related proteins LRP5 and LRP6. More than 10 Wnts and receptors have been identified. 11 In the absence of Wnt-signalling GSK3β is complexed with axin, β-catenin and APC (adenomatous polyposis coli protein). In this complex GSK3β phosphorylate and stabilize axin and APC increasing the ability of GSK3β to phosphorylate β-catenin. Here, axin plays the critical role in insulating GSK3β from other GSK3β-related pathways: non-axinassociated GSK3β has almost no activity toward β-catenin, 12 and axin-associated GSK3β is not regulated by insulin. Phosphorylation of β-catenin in the complex promotes its ubiquitin-mediated degradation by the proteasome. 8 Upon binding of Wnts to their receptors Dvl (Dishevelled in Drosophila) FRAT1 is mobilized disrupting the GSK3β/axin/APC/β-catenin complex by recruiting axin to the Wnt receptors. 7, 13 In this process nonphosphorylated β-catenin is released from the complex and translocates to the nucleus, where it binds to transcription factors of the TCF/LEF family of transcription factors. As in the insulin/Akt signalling pathway the reduced phosphorylation of axin by Wnt-stimulation may in part be mediated by action of protein phosphatase 2A (PP2A), which binds to axin. Also, PP2A may dephosphorylate APC in its cental region, decreasing the facilitation of β-catenin phosphorylation. 7 However, apart from the above described mechanism of regulation, the Wntpathway differs from the insulin pathway in that there is probably no prerequisite for priming phosphorylation of axin, β-catenin or APC by other kinases prior to phosphorylation by GSK3. Also, GSK3β is not phosphorylated in Ser9 by the Wntsignalling. Rather, GSK3β is made inefficient in this pathway by simply disrupting the phosphorylation complex. 3. Hedgehog pathway. Hedgehog is a group of related, secreted proteins. 14 Unique to hedgehog is the covalent coupling of cholesterol to the C-terminal end of the mature protein and the palmitoylation in a N-terminal Cys by an acyl-transferase. The cholesterol moity seems not to influence signalling but is important for secretion, whereas palmitoylation potentiates the signal activity. 15 The hedgehog receptor (Patched) is a twelve-pass transmembrane receptor that acts as a key inhibitor of the constitutively active seven-pass transmembrane G-protein-coupled receptor Smoothened. Binding of hedgehog relieves the inhibition of Smoothened activating the translocation of the transcription activator Cubitus interruptus (Ci) in flies (Gli in the mammalians). 16 In the absence of signalling in this pathway Ci is in part truncated and functions as transcriptional repressor, and is in part targeted to degradation. The latter is accomplished by a sequential process in which GSK3β along with casein kinase 1 and protein kinase A phosphorylates the 155-residue in Ci and this phosphorylation is the signal to degradation, 7, 13 very much similar to the Wnt-pathway targeting of β-catenin for degradation.
Thus, in this and in the Wnt-pathway GSK3β appears to repress transcriptional activity. It must be stressed that the hedgehog-patched signalling pathway is very complex and far from resolved involving many proteins, kinases and phosphatases. In addition this signalling system has many targets including Patched itself, Wnt-gene family, and members of the TGFβ superfamily and their second messengers. 14 4. Notch pathway. Notch signalling participates in several cellular processes the most important being preserving stem cells, cell-fate decision processes and induction of terminal differentiation, in all cellular ontogenese. 17, 18 Notch is a type 1 integral, single-pass transmembrane receptor, which are activated in trans by membrane bound ligands. 19 Initiating Notch signalling by receptor-ligand interaction between two cells is thought to be accomplished by dissociation of the extracellular part of the receptor followed by trans-endocytosis into the opposing cell. This is triggered by an extracellular metalloprotease TACE (TNFα-converting enzyme/ ADAM 17) cleavage of the receptor, [20] [21] [22] although other enzymes may be active in this process. 23 Cleavage of the intra-membrane portion of Notch by the γ-secretase complex follows, thereby releasing the cytoplasmic part of Notch (Notch-IC). 17, 19, 24, 25 This fragment enters directly into the nucleus and binds to the transcription factor Suppressor of Hairless. 26, 27 The nuclear transcription activity may be stabilized by GSK3-phosphorylation of intracellular/nuclear Notch-IC, 17 although this is debated. Recent studies demonstrates the crosstalk between Notch-signalling and the PIK3-Akt pathway, where activation of the latter (by e.g. insulin) inhibits GSK3β. 28 Termination of Notch signalling is accomplished by phosphorylation of the Notch intra-cellular signal protein and subsequent degradation by the ubiqutination-proteasome pathway. 27 5. Steroids. Steroids stimulates the transcription of the serum-and glucocorticoid-regulated protein kinase (SGK). This kinase is then activated by phosphoinositide-dependent protein kinases (PDK) which in turn activates Akt. In vitro both kinases inactivates GSK3β, i.e. SGK and Akt may substitute or complement each other. 29 Glucocorticoidinduced degradation (through Akt) of GSK3β prevents degradation of the cytoplasmatic pool of β-catenin, which is a component of microtubules and the adherence junction complex. 30 GSK3β itself is also recruited to the to the cellular adhesion complex 31 promoting on-location regulatory phosphorylation. Thus the dual function of β-catenin, as a transcription factor and as structural cellular component is regulated in completely different ways.
Several other GSK3β-regulating pathways acting through phophorylation of Ser9 has been identified. This includes kinases such mitogen activated protein kinases (MAPK) regulated by growth factors, amino acids through a pathway involving the rapamycin target mTOR, and by cAMP-dependent kinase (PKA). 5, 32 The mTOR pathway regulates the ribosomal p70/p85-S6 kinase, which in turn inactivates GSK3β. 33 Activation of the Fas receptor mediates apoptosis, but the mechanism is distinct from classical Akt/GSK3β pathway as it is the Fas-regulator c-FLIP, inhibiting the Fas-mediated recruitment of caspase-8/10, that reduces phosphorylation of both Akt and GSK3β at least in cardiomyocytes. 34 GSK3β activity are also modulated by dihydrofolate reductase (DHFR), which is the target for the anti-inflamatory drug methotrexat. The effect is probably not direct, but via changes in DNA-methylation altering the transcription levels. 35 Folate depletion has been shown to alter several components of the Wntpathway including APC and β-catenin 36 which would influence GSK3β activity. In addition, the expression of GSK3β itself may be influenced by altered methylation patterns in it s promoter, although this is speculative at the moment.
Recently, it has been discovered that calpain may truncate neuronal GSK3β, which increase the GSK3β activity. The exact significance of the cleavage is not known. 37 
physiology of GsK3β
Glycogen is the major storage form of glucose and its cellular level are tightly regulated by glycogen synthase, GSK3β, and glycogen phosphorylase. 38 GSK3β is regulated by insulin in a complex process as mentioned above and that involves phosphatidylinositol-3-kinase (PI3-K), 3-phosphoinositide-dependent kinase, PDK1, and protein kinase B (PKB/Akt) mediated phosphorylation of Ser9 in GSK3β. 5, 39, 40 However, GSK3β is involved in many pivotal processes, where regulation of the glucose metabolism is just one and maybe not the most significant.
Cell cycle and embryogenesis
GSK3β is involved in the meiotic process in the oocyte presumably by modifying spindle activity. 41, 42 Further, GSK3β is also of paramount importance in the cell cycle and embryogenesis, 43 but the outcome of the GSK3β activity is complex and far from elucidated. For instance, at least one of the isoforms of GSK3 are necessary for axon elongation in a critical period comprising at least the first 24 hours of axon formation. Inhibition of GSK3 after this period does not compromise elongation, but exacerbates axon branching. 44 GSK3β probably exerts its effect by phosphorylation of the microtubule-associated proteins MAP1B and tau reducing their binding to the microtubules. This renders the microtubules unstable and more dynamically active in axon growth. 45 
Ontogenesis of mesenchymal cells
The canonical Wnt/β-catenin pathway controls the differentiation of osteoblasts and chondrocytes. β-catenin is required for osteoblast development from the mesenchymal progenitor cell, and suppression of β-catenin induces differentiations to chondrocytes instead. 46, 47 In established chondrocytes the dysregulation of Wntpathway increasing β-catenin expression may be involved in development of osteoarthritis. 48 The increase of β-catenin may be accomplished by increased expression of Smurf2. This protein interacts with GSK3β inducing ubiquitination of GSK3β itself and subsequential proteasomal degradation. The final result is deprivation of GSK3β and hence reduced phosphorylation and degradation of β-catenin. 49 Thus, is seems that dysregulation of the signal pathway at this stage reverts the chondrocytes to an osteoblast-like behaviour with ectopic calcification of cartilage.
Muscles
GSK3β has been established as a kinase with strong anti-hypertrophic properties in cardiac muscle, 50 probably related to the apoptotic action of GSK3β. It has been suggested that (excessive) Wnt-signalling is causative in cardiac hypertrophy by re-activating a fetal gene program and by inhibiting GSK3β, but this remains to be firmly established. Wnt-independent mechanisms involving GSK3β (and β-catenin) has also been suggested 51 in this context. Activation of the Fas receptor, usually mediating apoptosis, has been associated with cardiac hypertrophy by inhibition of GSK3β. 52, 53 The natural regulator of Fas, c-FLIP, seems to have a protective role in the heart preventing cardiac hypertrophy. Overexpression of c-FLIP reduces phosphorylation of both Akt and GSK3β, suggesting that the hypertrophy is avoided at least partially by the action of GSK3β. 34 Interestingly, in zebra fish (Danio rerio) GSK3α, but not GSK3β is necessary for the survival of the cardiomyocytes, while GSK3β exerts its important functions in modulating right-left symmetry of the heart. 54 The signalling is through the PKC/ERK/RSK pathway and not through the Akt pathway. 55 Although our knowledge still is rather rudimentary, the anti-hypertrophic effect of GSK3β seems well established.
Apoptosis
GSK3β is pro-apoptotic and inhibition of GSK3β may prevent apoptosis. 56, 57 The mechanism is not clear, but may involve the nuclear transcription promoter NF-κB. The potential role of GSK3β may be tissue-specific.
58
NF-κB is retained as an inactive transcription factor in the cytoplasm by binding to the inhibitory protein IκB. When IκB becomes phosphorylated it is targeted for ubiquitin-dependent degradation, and NF-κB may enter the nucleus. Although GSK3β is thought to be instrumental in this process, the mechanism has not been unequivocally established. 58, 59 Another suggested mechanism is the inhibitory phosphorylation of translation initiation factor eIF2B by GSK3β. 60 Further support for the involvement of GSK3β in apoptosis comes from the findings that growth factors phosphorylation of GSK3 inhibits apoptosis. 61, 62 Withdrawal of growth factors induces apoptosis, which in addition can be prevented by lithium, a well-established inhibitor of GSK3β, although not entirely specific.
Nervous tissue
GSK3β facilitates staurosporine-and heat shockinduced neuronal apoptosis. 57, 63 The neuronal proapoptotic effects of GSK3β, measured as caspase-3 activity, is inhibited by valproate and lamotrigen supporting neuronal survival. This effects mimics the insulin/growth factor stimulation of Akt-inactivation of GSK3β. 64, 65 Heat shock can activate Akt and this can be inhibited completely by LY294002 and wortmannin, i.e. the activation of Akt is PI3K-dependent. Heat shock and other stimuli like cell injury, oxidation or osmotic stress, activates the heat shock factor-1 (HSF-1) transcription factor, 66 which in turn increases the expression of heat shock proteins conveying protection against lethal conditions. GSK3β suppress the activity of HSF-1 by phosphorylation of Ser303 in HSF-1. Also, inactivation of GSK3β (but not GSK3α) in the Wnt-pathway protects the neurons from apoptosis in the cerebellum. p53-induced apoptosis after DNA-damage involves binding of p53 to and activation of nuclear GSK3β. In this context GSK3β promotes p53-mediated transcription by phosphorylation of serine 33 in p53. [67] [68] [69] GSK3β accumulates in the nucleus during senescence of human fibroblast. Here the kinase is complexed with p53, and this interaction may promote senescence. 70 These are just a few examples of the more wellstudied effects of GSK3 and particular the β-form, but the ubiquitous espression of GSK3β in almost all tissues suggest involvement of the kinase in most cellular processes in development. However, much has to be done to establish the role of GSK3β.
GsK3β and Disease Diabetes
As mentioned above GSK3 earned its name by the discovery of its role in glucose homeostasis. Indeed, GSK3, and particularly the β-form, has been shown to be instrumental in this context and aberrant activity of the kinase has been linked to diabetes mellitus. GSK3β have two effects in the liver: it inhibits glycogen synthase and increases the expression of the gluconeogenetic genes glucose-6-phosphatase and phospho-enol-pyruvate carboxypeptidase increasing the glucose output. 71 GSK3β Ser/Thr-phosphorylation of insulin related substrate IRS-1, inhibiting tyrosinephosphorylation of IRS-1, may also be a part of the glucose homeostasis. Thus, increased GSK3β activity moves the physiological state of a subject in the direction of a diabetic phenotype. Inhibition of GSK3β improves the diabetic state through increased activity of the Akt-pathway stimulated by insulin. 7 
Alzheimers disease
GSK3α and -β are highly abundant in the brain. The kinases phosphorylates various nuclear, cytosolic and extracellular proteins and the three major regulatory pathways of GSK3 (Akt, Wnt, and growth factor pathways) are in operation in brain. 72 Processes such as synaptic transmission, axonal transport and cellcell interactions are regulated by GSK3. Also, GSK3 is involved in brain development and apoptosis. 73 Increased levels of GSK3β has been linked to the development of Alzheimer's disease and other neurodegenerative disorders 73 The mechanism includes modulation of interactions of β-amyloid, tau, presenilin and other proteins, as well as apoptosis and modulation of cholinergic signal transmission. 74 In particular, hyper-phosphorylation of tau resulting in neurofibrilar tangles has been implicated in Alzheimer's disease. Presenilin (PS1 and PS2) may function as a scaffold in a complex of presenilin, tau, GSK3β, the amyloid precursor protein (APP), and catenins. The mechanisms are however complex and far from elucidated. 75, 76 PS1 binds both tau and GSK3β facilitating the interaction of tau with GSK3β.
77 PS1 also forms complexes with GSK3β and β-catenin. 78 In addition, presenilin activates γ-secretase, which is involved in the cleavage of APP to amyloid-β peptides (Aβ, the hallmark of Alzheimers disease) and is instrumental in the Notch pathway. The latter probably implicates a cross-talk with the Wnt-pathway, implicating the latter in development of Alzheimer's disease. 74 Thus, GSK3 is involved en formation of the two major components in Alzheimers disease, the amyloid plaque and neurofibrilar tangles. Finally, diabetes type 2 and Alzheimers disease (and schizophrenia) share overlapping pathology in the insulin resistance and amyloidogenesis through the PI3K/Akt/GSK3β pathway in the brain. Insulin receptor mRNA and receptor protein are present in discrete areas in the brain, but differs in several aspects compared to the peripheral insulin receptor. The co-occurrence of insulin resistance and amyloidogenesis mutually accelerates both, but the exact mechanism is not clear. 79 Various other neurodegenerate conditions have been associated with dysregulation of specific Wntand Notch-pathways (see) 80 for a presentation).
Mental disorders
Dysregulated serotonin (5-hydroxy tryptophan, 5-HT) is involved in many mental conditions as schizophrenia and autism, depression and bipolar disorders, and anxiety. Stimulation of the two serotonin receptors 5-HT 1 and 5-HT 2 respectively enhances or reduces Ser9 phosphorylation of GSK3β, and hence reduces or enhances the activity of GSK3β, respectively. Mutations (artificial) in the rate-limiting enzyme for 5-HT synthesis, tryptophan hydroxylase 2 (Tph2) reduces the 5-HT level in frontal cortex in mice by ~80% with a concomitant activation of GSK3β, 81 but the exact involvement of GSK3β in the mental conditions is unclear. Activation of dopamine-like receptors (D2-like) activates GSK3β, through dephosphorylation of Akt in a complex involving β-arrestin-2 and the protein phosphatase PP2A. Thus, Akt is inactivated thereby releasing the Ser9 phosphorylation of GSK3β. 82 There has been reports of dysfunction of the Wntpathway in schizophrenia resulting in altered GSK3-activity and reduction in β-and γ-catenin in the frontal cortex. 72, 83, 84 However, some studies does not find any alterations in β-catenin, Dishevelled or GSK3β in the prefrontal cortex in schizophrenia, bipolar disorders or major depression. 85 Clearly, GSK3β is involved in both neurodegenerative conditions and mental disorders, but many issues are unsolved. It is difficult to study brain function, but the association to common conditions as diabetes mellitus may open new avenues to entangle at least some of the processes in the brain, despite the shortcomings, limitations and pitfalls there obviously may be.
Cancer
GSK3β is overexpressed in several colon cancer cell lines, which does not seem to influence β-catenin accumulation in the nucleus. Inhibition of GSK3β may promote apoptosis in these cells, 86 contrary to the supposed apoptotic effects of GSK3β in normal cells. In fact, the impact of GSK3β depends on the tumour: GSK3β may be a tumour suppressor in skin and mammary cancers, but functions as a tumour promoter in colon and pancreatic cancers. 87 Thus, the diverse actions of GSK3β is not a feature of the kinase per se, but rather is consequence of aberrant activity in the interactions with other proteins and metabolics in the various networks GSK3β is a part of.
Several oncogenes are modified by GSK3β, 88 such as MUC1 and c-Myc. 89 MUC1 is overexpressed in a variety of tumours and may sequester β-catenin, thereby inhibiting formation of the E-cadherin/β-catenin complex contributing to reduced cell-cell and cell-matrix interactions promoting invasiveness of tumour cells.
Phosphorylation of MUC1 by GSK3β is proposed to reduce the MUC1-β-catenin interaction. 7 DNAdependent protein kinase (DNA-PK) modulates the c-Myc oncogene by phosphorylation of Akt. As usual this results in reduced GSK3β and in this context reduced phosphorylation of c-Myc. Deficiency of DNA-PK kinase decreases the phosphorylation of Akt leading to increased activity of GSK3β, which in turn phosphorylate and stabilize c-Myc. 89 Adding to the list of GSK3β in cancer, breast cancer often displays abnormalities in the PTEN/PI3K/Akt/β-catenin pathway. 90 Only a few genic germ-line mutations have been reported with unknown clinical impact (see below). Most interestingly, mutations in GSK3β has been detected in sputum from patients with lung carcinomas. 91 The mutations or polymorphisms are all present in introns, suggesting that the dysregulation of the kinase may be the important factor, and not functional mutations in the gene per se. However, none of the mutations could be established as monogenic and are also detected in non-carcinomatous tissue, hence must be put in context of a larger genetic network of genes related to cancer development. Nevertheless, these observations suggests that even cancers, often supposed to be sporadic, may in fact be polygenic in nature and at least for some sub-populations of cancers they may be inherited.
In summary, GSK3β is involved in such a large amount of processes, that you may ask if genetic variations of this kinase per se is the cause of aberrant behaviours in many physiological functions and disease. A priori you may anticipate that any genetic variation, at least in the functional part of the gene i.e. the protein, would have such a diverse impact that it would be incompatible with life. Below we will provide evidence that GSK3β is in fact a highly conserved protein, with only few mutations allowed, which would classify GSK3β as an evolutionary and functional ultraconserved protein.
Methods

Evolution of GSK3β
The species included in the analysis covers the phylogenetic evolution back to Precambrian periods. The phylogenetic timeline were deducted using the TimeTree programme, 92 which uses databases including molecular data from hundreds of studies of the molecular clock. The programme makes extensive use of the NCBI Taxonomy browser, which in August 2009 contained nucleotide sequences from more than 300,000 organisms. 93, 94 A particular advantage of the programme is that time estimates of divergence of two species are traced back to the same node irrespective of which member of the lineages are queried. Both nucleotide (genomic and mitochondrial) and protein data are included in the calculations, which necessarily introduces variability of the estimates. The number of estimates and the number of genes included in the calculation of molecular distances varies considerably and there may be ambiguities about the node of divergence.
Molecular details from recent studies were obtained from the sources (e.g.) 92, [95] [96] [97] [98] [99] and see the links in the TimeTree programme), but in some instances a species could not be placed accurately in the phylogenetic tree and the first occurrence of the nearest ancestor was used instead. Also there may be differences in estimates between fossil and molecular trees. These inaccuracies is however of lesser importance as the issue here is the position on the timeline, not the exact evolutionary distance between species.
DNA and protein sequences of human GSK3β were aligned using the Blast algorithms 100 to all species directly accessible from National Centre for Biotechnology Information, NCBI (http://www.ncbi.nlm. nih.gov). The alignment was done for the full coding sequences and translated proteins as well as the exons and the exon-encoded peptides separately. The latter could be ambiguous in the terminals of the peptide as many codons are assembled by two exons. In this instances the amino acids were included in both exons in the search process. The most recent build of the sequence databases were used.
insulin resistance
Due to the essential role in glucose homeostasis, it has been hypothesized that variants in the GSK3β genes are risk factors that predispose to insulin resistance and type-2 diabetes. Besides frank diabetics several other conditions have a co-morbidity with insulin resistance including schizophrenia 101 and 40%-60% of HIV-patients in antiviral treatment. 102, 103 Therefore, all the exons, including the splice site regions were sequenced to detect any mutations/polymorphisms related to insulin resistance. The patients were sampled from three different biobanks: 20 subjects with diabetes mellitus type 2 (Diabetes Biobank, Hvidovre Hospital, Denmark); 26 patients with schizophrenia (Danish Psychiatric Biobank, Sct. Hans Hospital, Denmark); and 26 HIV patients from (The HIV Biobank, Hvidovre Hospital, Denmark). All subjects suffered from insulin resistance and all patients represent the extreme phenotypic expression of their primary disease. DNA was extracted from whole blood using standard methods. Details of the primer design can be found in the Supportive material.
Population
Several polymorphisms have been detected in human GSK3β, but most are not validated thoroughly. Therefore, we genotyped a large randomly sampled population (Monica 10) to validate the polymorphisms and if present, their relation to clinical outcomes. The Monica 10 population 104, 105 were genotyped for most of the exonic GSK3β single nucleotide polymorphisms (SNP) included in the dbSNP database maintained by NCBI. The Monica 10 study population has been described in detail elsewhere. In brief, Monica 10 consisted of 2,656 re-invited participants (1993 to 1994) who originated from the Danish part of the monitoring of trends and determinants in cardiovascular disease (MONICA) health survey, 106 which was performed from 1982 to 1984. The present genotyping in addition included 173 participants from the original sample not included in the Monica 10 sample. In total 2,829 subjects were genotyped for 6 of the 9 reported SNPs in human GSK3β. The genotyping of Monica 10 was performed by KBioscience, Manchester, UK.
The genotyping of the patients and Monica was approved by the ethics committee for Copenhagen County, Denmark. Written informed consent was obtained from all participants. Table 1 summarizes the alignment of human GSK3β protein and DNA sequences with several animal species covering evolutionary time back to Cambrian period 540 million years ago (Mya). Table 2 summarize data for species originating in the Pre-Cambrian periods. (GSK3α is mainly included to illustrate the extent of similarity to GSK3β). The timeline is constructed as the average of estimates for the molecular divergence of the species from Homo sapiens without trying to evaluate the validity of single studies, although TimeTree offer an expert evaluation. Mostly this timeline is in accord with fossil time lines. Some ambiguity are, however, present particularly in ordering the subphyla of chordates. 107 Chordates, a monophyletic group sharing a specific body plan, consists of three subphyla: urochordates (here represented by Ciona intestinalis), cephalochordates (here represented by Branchiostoma floridae), and craniata or vertebrates. The relationship between these three subphyla is however murky. Using genomic data the cephalochordates may be declared the basal chordate subphylum predating urochordates and vertebrates, the latter two being sisters. 108 However, mitochondrial data would suggest that urochordates are the basal subphylum. 107 Recent studies using protein data in the molecular clock estimates suggest that the urochordates diverged from cephlohcordates in the Precambrian period about 900 Mya and from vertebrates about 800 Mya, that is in the Cryogenian period. 97, 99 The hemichordates and echinoderms (worms, sea urchins) as well as the protostomians (the other major clade of bilateral animals), which includes arthropods and nematodes, also dates back deep in the Precambrian period. 98 Thus, the crown group of animals diverged long before the ecological Cambrian explosion. The cradle of animal life lies in the Cryogenian period (635-850 Mya) and the emergence of bilaterian taxa arose in the Ediacaran period (from 635 and up to the Cambrian explosion), and since then the higher-level taxa have developed in separate lines. It should be noted that the molecular estimates are about 300 Mya earlier than the fossil records would suggest.
Results
The platypus and marsupials/eutherian are descendent of ancestors in distinct geographical areas, and it has been disputed if these monophylic divisions are members of the same clade according to the Thera hypothesis. 109 The platypus together with the echidna are the only extant egg-laying mammals (monotremes). They diverged from birds 325 Mya exactly as Homo sapiens did. The important issue here is however, not the exact time of divergence of the species (not least considering the uncertainty in the estimates of the divergence), 110 but rather the hierarchical location on the time line and position in the phylogenetic tree, as when the split occurred evolutionary events in the species proceeded independently of the common ancestor. The prominent members of the primates, gorilla and orangutan are not included here due to lack of or only sparse sequence data are available in the NCBI databases.
Several striking results emerge. First, the entire GSK3β protein is highly conserved among vertebrates. This conservation dates back at least to the divergence of amniota into mammals and birds about 325 Mya, and only deteriorated slightly in amphibians and fish, the divergence to Homo sapiens dating back 455 Mya. The high degree of homology is reflected by the almost complete homology between most of the exon-coded peptides of GSK3β in mammals and to somewhat lesser extent for some of the remaining vertebrates in the table.
Second, peptides encoded by exon 3, 6, 7 and 8 are completely conserved in all species and this is also true for exon 1, 2, 5 and 10 in mammals, except for the old world monkey Cynomolgus and platypus. The complete conservation of peptides encoded by exon 1, 2 and 5 extents to birds, while the frog and fish peptides are next to complete for these exons. Thus, the conserved regions harbours the serine/threonine kinase active domain located in exon 5 and the tyrosine kinase activity mapped to exon 3, although the protein sequence 56-353, encoded by exon 2 to 10, is involved in the kinase activities. Thus, the functionally most important domains of the enzymes seems to have been conserved almost to completion since the Cambrian explosion.
Third, homologies of exon 1, 11 and 12 is high in vertebrates except in platypus. In non-vertebrates (Table 2 ) the homologies in these exons deteriorate rapidly, suggesting species-specific functionalities (if any) of these exons. Some divergence is detected for exon 11 and 12 peptides in vertebrates, but still the similarities are very high. The homologies to the two Macaca are rather low. These peptides are annotated to be GSK3α peptides and has a high similarity to several of the other vertebrate GSK3α including man, chimpanzee, dog, cow, rat and mouse. The actual sequence of the exon 11-encoded peptide for the Macaca's is unresolved.
Exon 9, coding a complete 13 amino acid stretch, is somewhat ambiguous, in the sense that it were not detected in its full length in many of the species, including mammals. However, at least in vertebrates this may be caused by technical problems in the sequencing procedure (shot-gun sequencing), and may not be real. In non-vertebrates the alignments are poor for this exon, which very well may be real, but considering the rather high level of homologies detected for most of the other exons (particular the flanking exons 8 and 10), it could possible be that exon 9 for some unknown reason may be difficult to sequence. This is also reflected in the inconclusive and incomplete sequences alignments detected, particular in non-vertebrates. The homology of the nucleotide sequences may often seem rather low, but in many instances shorter stretches with perfect match are detected while the remaining sequence is missing most probably for technical reasons. Analysis of Strongylocentrotus purpuratus and Nematostella vectensis revealed a perfect similarity of 8 consecutive amino acids in the exon 9-encoded 13 amino acid peptide. None of them were annotated as being GSK3β related and for Nematostella vectensis the protein is simply quoted as predictive to be a protein.
However, considering the probably general problem in sequencing this exon it may be suggested that the exon or at least the peptide coded by the exon 9 is highly conserved deep into the Precambrian period. Thorough re-sequencing is needed to confirm this hypothesis.
A survey of selected non-animal species revealed high similarities in the exon 5, 6, 7, and 8-encoded peptides. The homology to the human peptide is absolute for the exon 7-encoded peptide for Triticum (wheat) and Aegilops (flowering plants), 97.1% for Zea mays (all species with a predicted molecular distance from Homo sapiens of 1,400 Mya), and 96.7% for Oscarella lobularis (marine sponge) with a molecular distance of 1,020 Mya. The homologies are somewhat less for the other three peptides ranging from 80% to 91%. Nevertheless, the homology is extremely high for these peptides covering 1/3 of the entire enzyme, and most importantly includes the pivotal enzymatic active domain of GSK3β.
A closer look at the vertebrate protein sequences (Supporting material T2) reveal that many of the dissimilarities to Homo sapiens are deeply rooted. Almost all differences are caused by single nucleotide mutations and many may in fact be ambiguous as more than one amino acid substitution are predicted. The only non-synonymous substitution detected to be heterozygotic in human is residue 152 in exon 4. This residue is an alanine in Xenopus, but a Thr-Met substitution is suggested to be present in man (a C-T changes in position 2 of the codon). None of the other substitutions in the table (Supporting material T2) has been detected as polymorphic in man. The substitution rates for the amino acids are extremely low. In the vast majority of exon-coded peptides no substitutions are detected at all. The lowest substitution rate (disregarding Macaca fascicularis) is seen in exon 2 for Danio rerio (5.1 E-11 substitutions per year in the peptide), which is far lower than expected for neutral substitutions (see) 111 for a discussion). More to the point is that most exon-coded peptides are invariant deep in the phylogenetic tree, and, particularly for exon 7, the invariance extents 1,400 Mya to wheat and plants. Again, this may be on the conservative site due to not entirely reliable sequence data for many species (including Macaca and platypus).
The protostome (the other major bilaterian) annelid Pltynereis dumerlilii did reveal some modest homology to GSK3β, but the protein is annotated as a Junkinase, and the stretches of homology did not extend beyond four amino acids and have many gaps. The overall homology is 31% and only 41% for the highly conserved exon 7-coded peptide. This is in sharp contrast to some plants like Tricitum and Aegilops (100% amino acid homology to the exon 7-encoded peptide) and several other plants and trees with homologies in range of 84 to 97% for this peptide (not shown). All of these latter species are estimated to diverge from human apporximately 1,400 Mya (not shown).
The DNA sequences are not as conserved as the protein sequences, which is to be expected as many mutations results in synonymous substitutions of amino acids and the selection pressure is on the functionality of the proteins and not the DNA sequences per se. For gorilla and orangutan (Pongo) only sparse protein and DNA homologies were obtained. It is unlikely that these species, which diverged less than 15 Mya from Homo sapiens, do not posses the genes for GSK3β. Rather, sequencing may be incomplete at the moment. In fact, many of the alignments may be curtailed by less than optimal and thorough sequencing, and hence the homologies may be underestimated. The 3'UTR region is highly conserved in the vertebrate species where solid sequence data is available (Table 1) .
Genotyping in homo sapiens
In the patient samples all 12 exons were successfully amplified and sequenced in all patients with the exception of exon 1 which could not be determined in one subject with diabetes mellitus type 2. We did not find any new mutations in any of the examined exons, nor in the intron/exon splice site regions in any of the subjects. Nine exonic GSK3β SNPs are included in the dbSNP database (Table 3) , and no other exonic SNPs have been found. Detailed data is missing for some of the SNPs and some are not validated. Three of the reported SNPs are non-synonymous and 6 are synonymous. The polymorphisms in exon 2, 4 and 10 (rs72548709) have been detected in one Asian subject, while rs17183904 in exon 10 and rs72548719 in exon 11 were only detected in African Americans. All three missense SNPs were genotyped in the Monica population and three of the synonymous were genotyped to cover the all exons in which SNPs have been detected. Only SNP rs72546694 (synonymous) in exon 5 and rs34009575 (missense) in exon 9 were non-monomorph with two genotypes: the so-called wild-type and a few heterozygotes (7 for rs72546694 and 6 for rs34009575). The 6 subjects heterozygotes for the missense mutation in exon 9 were tracked down in the Central Disease and Death registers in Denmark. One have died from a bronchial neoplasma, one suffered from prostate cancer, one has a mixture of rheumatological symptoms, one has osteroporoses, and the two remaining subjects are healthy. All subjects are now 57 years old or older. Thus, the polymorphism cannot clearly be related to any specific clinical entity although the power of this conclusion is rather low.
Discussion
GSK3β is highly conserved in mammals and vertebrates with homologies on the protein level and to some lesser extent on the nucleotide level. Although the similarities to humans are somewhat less extensive the homologies extent back to the Cambrian explosion and even before. Particularly, some of exons are highly conserved way back to exoskeletonian species. The conservation of GSK3β is significant compared to average homology between species of e.g. transcription factors. 112 The only non-synomous mutation detected in the large Monica cohort could not be associated with any single disease, and in fact for two of the subjects no disease has been registered so far (August 2009). Also, no mutations were detected in the diabetes mellitus type 2 populations and the two populations (schizophenics and HIV-treated patients). The subjects in these populations were selected as the most extreme in their primary diseases arguing that these samples should present themeself with mutations in GSK3β if the kinase should in fact have any patophysiological relevans. This assumption may flawed, but nevertheless the results do not support GSK3β as a major factor in these diseases or the co-morbidity of schizophrenia or drug-induced insulin resistance in HIV-treated patients.
An interesting question is if the conservation of a gene or rather its encoded protein extents to the network it is part of, here GK3β in the numerous signal transduction networks it is a part of. The conservation of selected up-stream pathway-proteins and β-cartenin were therefor evaluated (Table 4) . Sequence comparisons were only done for the entire protein transcripts as it is not the scoop of this presentation to evaluate every single protein on the exon level. The conservation is substantial in the Post-Cambrian species, but rapidly decreases in the Pre-Cambrian species. The notably exceptions are Akt, β-catenin, and cAMP-dependent protein kinase (PKA), but in particular the catalytic subunit of the protein phosphatase 2 A (PPP2CA in Table 4 ) is conserved deep down in the Pre-Cambrian periods and even to a greater extent than GSK3β. Although Akt, β-catenin and PKA is not conserved to the same degree as GSK3β, some of central players in the major signal transduction pathways are very conserved. This is not the case for the more peripheral elements in the signal transduction pathways, but it is clear that the nidus of the GSK3β-related pathways is rooted deep in the Pre-Cambrian. Considering the plethora of processes GSKβ is participating in and the conservation between species, suggest that GSK3β functions as a hub integrating several metabolic networks. Hubs in networks are extremely fragile and sensitive to perturbations, [113] [114] [115] so at least heuristically it can be understood that functional mutations in GSK3β are strongly selected against. Recently a -50T/C transition in the promoter has bee suggested to be related to the onset of bipolar disease, but not the disease itself, 116 i.e. the coding sequence are preserved while variations may exist in the regulatory sequences. This would support the theory of facilitated variation put forward by Gerhart and Kirschner, 117 which suggest that the major genetic evolution and differences between species is caused by differences in regulatory structures rather than in protein-coding sequences, at least for GSK3β. It should be noted that polymorphisms outside the coding regions of GSK3β including the introns runs in the thousands, supporting the Gerhart-Kirschner theory (although the species-specific variations has not been examined).
The results presented here shows that ultraconserved proteins is in fact present, but the extent and number of ultraconserved proteins is not known.
Nearly 500 absolute conserved elements defined as segments of more than 200 bp in length with 100% identity (and no insertions or deletions) have been detected in the human and rodents (rat and mouse) genomes. These ultraconserved elements have in addition been found to be extremely, although not completely, conserved in chicken and dog (95% and 99%, respectively). 118 The elements are distributed in all human chromosomes except chromosome 21 and Y. One hundred and eleven of the 481 detected ultraconserved elements are partly overlapping exonic protein-coding regions, 256 are Empty fields denotes less than 5% of similarity, small stretches 3 amino acids of less in length or no sequnece was available.
The Question marks denotes ambiguities in the interpretation of the detected sequences or unexpected low similarities. a Exon 10 is not included but several clones include exon 10 with modest similarity to the human form. b Exon 8 is not detected. c Only exon 9. d Polymorphisms in exons (all/non-synonymous amino acid substitutions). e Polymorphisms in intronsd and 5'-and 3'-UTR areas as collated in dbSNP.
f Rate of non-synonymous substitutions pr amino acid in the protein.
non-exonic, while the classification of the remaining elements is inconclusive. The non-exonic elements are located in introns and integenic regions and tends to cluster close to transcription factors and early developmental genes. The exonic elements are highly enriched in RNA binding, splicing regulating, and DNA binding genes, while the non-exonic elements are particularly enriched in DNA binding genes including transcription factors and homebox genes. In contrast to the extreme conservation of these elements in vertebrates, only 5% of the ultraconserved elements could partially be traced back to Ciona intestinalis, Drosophila melanogaster, or Caenorhabditis elegans. 118 It should be noted that the ultraconserved elements in 1 are ultraconserved nucleotide sequences including only parts of exonic elements and not full genes. The results presented here extends the concept of kernel genes 1 not only to be transcription factors but also to include essential and highly preserved signal transduction pathways and entire genes.
In conclusion, GSK3β is ultraconserved, 118 and the functional diverse and essential modular processes GSK3β is part of, would suggest that GSK3β (and PPP2CA) qualifies to be a member of the probably very exclusive club of functional kernel structures. The data argue that the ultraconserved GSK3β and particular some of the exons are under a strong purifying selection pressure, and are functionally highly constrained as also suggested for the ultraconserved DNA elements.
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Forward primer
Reverse primer
Exon 1 5′-TTTAGGATTTGTCCTCTC-3′ 5′-AGATCCTGGTATTTCGAGGTT-3′
Exon 2 5′-ACCTTGTATATTTTGGCAGTT-3′ 5′-AAAATGCGCACAATAGA-3′
Exon 3 5′-CATCTTGTTCAATATGATGA-3′ 5′-AAACTGTCTATGAGCG-3′
Exon 4 5′-TTTAAAAATCCGAATAAG-3′ 5′-AGTTTTTCTCCCTGAGTATTA-3′
Exon 5 5′-TCTGTTACTTTATTGACTGCT-3′ 5′-AATTACTGTGTTTAGGCT-3′
Exon 6 5′-GATACTGTGAAAGGATAGCAGTC-3′ 5′-AACATTATGGGATATATCCA-3′
Exon 7 5′-ATTGTATAATCTTTTCCTGTGAT-3′ 5′-AAAAATTCCTTCCAGTTCAA-3′
Exon 8 5′-CCTGAAAACATGGAGACTAAAT-3′ 5′-ATACAACTATCTTTACATGCAGA
Exon 9
5′-CCACACCATGGATTTCTTATAAC-3′ 5′-TGAAACCTATGCCATACAGT-3′
Exon 10 5′-ACAGGGTATTTGCTTAGATTCTT-3′ 5′-GTACTTAATATGTCCGTTTTTG-3′
Exon 11 5′-CCCGGCATAAACTGGTAGT-3′ 5′-ACACCTGGCTAAGTTTTT-3′
Exon 12 5′-CTTGGAAGGCCATACAGT-3′ 5′-CTTTTTAATATTCTTTCCAAACG-3 supporting Material Table s . Alignment of amino acid sequences of vertebrates for stretches with less than absolute similarity.
exon
Homo sapiens MSGRPRTTSFAESCKPvQQPSAFGSMKvSR
Xenopus laevis MSGRPRTTSFAESCKPvQQPSSFGSMKvSR
Ornithorhynchus SERPRTPSFGES
Tetraodon MSGRPRTTSFAESCKPvPQPSAFGSMKvSR
Danio rerio MSGRPRTTSFAESCKPvPQPSAFGSMKvSR exon
Homo sapiens DKDGSKvTTvvATPGQGPDRPQEvSYTDTKviGNGSFGvvYQAKLCDSGEL
Xenopus DKDGSKvTTvvATPGQGPDRQQEvTYTDTKviGNGSFGvvYQAKLCDSGEL
Macaca fascic DRDSGKvTTvvATLGQGPERSQEvAYTD i KviGNGSFGvvYQARLAETREL
Homo sapiens vAiKKvLQDKRFK
Xenopus vAiKKvPQDKRFK
Macaca fascic vAiKKvLQDKRFK exon 3
No dissimilarities exon
Homo sapiens KDEvYLNLvLDYvPETvYRvARHYSRAKQTLPviYvK
Pan troglodytes KDELYLNLvLDYvPETvYRvARHYSRAKLT i PiLYiK
Macac fascic KDELYLNLvLEYvPETvYRvARHFTKAKLT i PiLYiK
Spermophilus KDvvYLNLvLDYvPETvYRvARHYSRAKQTLPviYvK
Monodelphis KDEvYLNLvLDYvPETvYRvARHYSRAKQTLPLiYvK
Taeniopygia KDEvYLNLvLDYvPETvYRvARHYSRAKQTLPLiYvK (Continued)
